Accelerate to discover
Related topics
Webinar recording: Analysis of extracellular vesicles by AMNIS imaging flow cytometer
Nov 4, 2019
Although conventional flow cytometry is limited to measure small particles down to approximately 300 nm – 500 nm, an...
Targeted mitochondrial DNA extraction and enrichment using the SageHLS
Oct 31, 2019
Sage Science introduced a novel approach for enriching mitochondrial DNA for sequence analysis without PCR or gradient...
Oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer at a single low dose
Oct 24, 2019
Pancreatic ductal adenocarcinoma (PDAC) has been increasing by 0.5% per year in the United States. This study describes...
Bionano ICS software upgrade: 2600 Gbp with new instrument control software for Bionano Saphyr
Oct 24, 2019
Upgrade to Instrument Control Software v4.9 for higher throughput. Saphyr Instrument Control Software (ICS) v4.9 is the...
New code dedicated to esophageal procedures with Confocal Laser Endomicroscopy
Oct 21, 2019
Announcement of the creation of a new specific procedural code to be added to the Common Classification of Medical...
Flow cytometry technology in an affordable instrument - Discover Guava Muse
Oct 21, 2019
Sophisticated cell analysis doesn’t have to be complicated or costly. With the Guava Muse cell analyzer, you can now...
Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample
Oct 17, 2019
Cytek Aurora turning aspirations into realizations: 40 Colors, One Tube. Until recently, developing fluorescence-based...
Sep 27, 2019
VisualSonics AutoLV allow functional and anatomical analysis of the left ventricle in one click using the power of...
May 18, 2016
With the increasing need for new therapies for cancer, autoimmune disorders and Alzheimer’s disease, monoclonal antibodies are proving very successful due to their high affinity and specificity for their target antigens. In cancer, for example, their first use was as antagonists of oncogenic receptor tyrosine kinases, but today monoclonal antibodies have emerged as vehicles for the targeted delivery of potent chemotherapeutic agents and as powerful tools to manipulate anticancer immune responses. Currently,
more than 30 antibody therapeutics are marketed worldwide. Some analysts predict that, given the rate of current revenue growth and potential new approvals, the global market could reach $58 billion by 2016. In addition, there are hundreds of monoclonal antibody-based biologic drugs in various phases of clinical trials worldwide.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
